The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
05/24/2023 | Robin Cohen | 3 min read
“The world has long needed a better vaccine delivery system.” The time of the hollow needle is over – solid dose vaccines are the future.
05/22/2023 | Jamie Irvine | 2 min read
Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development
05/19/2023 | Jamie Irvine | 3 min read
Self-assembling “super-sized” nanocages could encapsulate and deliver drugs to specific targets in the body.
05/18/2023 | Jamie Irvine | 2 min read
The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer
05/17/2023 | Sponsored by Bio-Rad Laboratories | 6 min read
There are many ways to generate antibodies, but sometimes traditional methods don’t deliver what you need.
05/17/2023 | Jamie Irvine | 2 min read
Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance
05/16/2023 | Jamie Irvine | 6 min read
Anti-aging company – Five Alarm Bio – reveal their discoveries on safe and effective treatments for age-associated diseases and disabilities
05/15/2023 | Jamie Irvine | 2 min read
Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.
05/12/2023 | Jamie Irvine
Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy
05/11/2023 | Sponsored by Bio-Rad Laboratories | 6 min read
How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.
05/10/2023 | 3 min read
Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa
05/09/2023 | 3 min read
An insight into the research fuelling developments for universal cancer immunotherapies
04/26/2023 | Sponsored by Bio-Rad Laboratories | 8 min read
Will next gen antibodies knock our socks off? Experts consider the future of antibody-based drug development
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse